Learn More
Apexbio Technology LLC Melanocyte stimulating hormone release inhibiting factor 2002-44-0 5mg

Supplier: Apexbio Technology LLC A11215
Melanocyte stimulating hormone release inhibiting factor is a small endogenous tripeptide modulator targeting -melanocyte-stimulating hormone ( -MSH) release and dopamine D2/D4 as well as opioid receptors It is designed to inhibit -MSH secretion and modulate dopaminergic and opioid pathways thereby regulating neuropeptide and neurotransmitter signaling Melanocyte stimulating hormone release inhibiting factor exerts its biological activity primarily by allosteric agonism at dopamine D2/D4 receptors and antagonism at opioid receptor sites in addition to inhibiting -MSH release Based on these pharmacological properties melanocyte stimulating hormone release inhibiting factor holds research potential in studies of dopamine signaling opioid pharmacodynamics and neuropeptide regulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.